Travelers Sues Cephalon Over $17M In Actiq Claims

Law360, New York (July 24, 2012, 8:26 PM EDT) -- Travelers Companies Inc. on Tuesday fired back at Teva Pharmaceutical Industries Ltd. unit Cephalon Inc. in the insurer's fight to recover $17.5 million in paid workers’ compensation claims, accusing the companies of deceptively pedaling off-label uses of a cancer painkiller to boost profits.

In the suit filed in Pennsylvania federal court, Travelers accuses Cephalon of purposely misrepresenting the safety, efficacy and appropriateness of Actiq by promoting it to other doctors and specialists as a general painkiller for injuries such as burns, bone fractures, contusions and concussions....
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.